NovaBay Pharmaceuticals, Inc. (NBY)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 01:17PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.53M |
| Enterprise Value | 4.09M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.02 |
| Price/Book (mrq) | 1.85 |
| Enterprise Value/Revenue | 0.28 |
| Enterprise Value/EBITDA | -0.85 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.01 |
| 52-Week Change 3 | -94.87% |
| S&P500 52-Week Change 3 | 21.23% |
| 52 Week High 3 | 1.9500 |
| 52 Week Low 3 | 0.0700 |
| 50-Day Moving Average 3 | 0.1278 |
| 200-Day Moving Average 3 | 0.3508 |
Share Statistics
| Avg Vol (3 month) 3 | 3.53M |
| Avg Vol (10 day) 3 | 3M |
| Shares Outstanding 5 | 30.1M |
| Implied Shares Outstanding 6 | 30.1M |
| Float 8 | 29.93M |
| % Held by Insiders 1 | 0.03% |
| % Held by Institutions 1 | 3.30% |
| Shares Short (Mar 28, 2024) 4 | 718.77k |
| Short Ratio (Mar 28, 2024) 4 | 0.29 |
| Short % of Float (Mar 28, 2024) 4 | 2.39% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 2.39% |
| Shares Short (prior month Feb 29, 2024) 4 | 271.72k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:35 |
| Last Split Date 3 | Nov 16, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -65.46% |
| Operating Margin (ttm) | -21.41% |
Management Effectiveness
| Return on Assets (ttm) | -24.59% |
| Return on Equity (ttm) | -139.02% |
Income Statement
| Revenue (ttm) | 14.73M |
| Revenue Per Share (ttm) | 3.49 |
| Quarterly Revenue Growth (yoy) | 2.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4.8M |
| Net Income Avi to Common (ttm) | -16.7M |
| Diluted EPS (ttm) | -3.9600 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.13M |
| Total Cash Per Share (mrq) | 0.1 |
| Total Debt (mrq) | 2.74M |
| Total Debt/Equity (mrq) | 82.68% |
| Current Ratio (mrq) | 1.67 |
| Book Value Per Share (mrq) | 0.12 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4.13M |
| Levered Free Cash Flow (ttm) | -173.88k |
© 2024 Yahoo. All rights reserved.